1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 1,267 results.

Thumbnail for Comparative Toxicity of Menin Inhibitor-Based Combination therapy in newly diagnosed Acute Myeloid Leukemia: Venetoclax-containing Versus Non-Venetoclax regimens

AML - 858

Comparative Toxicity of Menin Inhibitor-Based Combination therapy in newly diagnosed Acute Myeloid Leukemia: Venetoclax-containing Versus Non-Venetoclax regimens

Vaishnavi Rao

Poster Presenter: Vaishnavi Rao

Thumbnail for Postmarketing Safety Signals of Revumenib (Menin-KMT2A Inhibitor) vs Acute Myeloid Leukemia-Targeted Therapies: A Class-Restricted Disproportionality Analysis of the FDA Adverse Event Monitoring System (2016-2026)

AML - 867

Postmarketing Safety Signals of Revumenib (Menin-KMT2A Inhibitor) vs Acute Myeloid Leukemia-Targeted Therapies: A Class-Restricted Disproportionality Analysis of the FDA Adverse Event Monitoring System (2016-2026)

Arashdeep Singh

Poster Presenter: Arashdeep Singh

Thumbnail for Characteristics and Clinical Outcomes of DDX41-Mutated Myeloid Neoplasms Treated with Lenalidomide: Single-Center Retrospective Study

AML - 872

Characteristics and Clinical Outcomes of DDX41-Mutated Myeloid Neoplasms Treated with Lenalidomide: Single-Center Retrospective Study

Jacob Herstein

Poster Presenter: Jacob Herstein

Thumbnail for Treatment Intensity Does Not Improve Survival in TP53-Mutated Acute Myeloid Leukemia: Real-World Outcomes From a Racially Diverse Academic Center

AML - 897

Treatment Intensity Does Not Improve Survival in TP53-Mutated Acute Myeloid Leukemia: Real-World Outcomes From a Racially Diverse Academic Center

Eiline Cai

Poster Presenter: Eiline Cai

Thumbnail for Effect of Nonselective ί-Blocker Use on Postallogeneic Stem Cell Transplant Outcomes in Patients with Myeloid Neoplasms: A Trinetx-Based Retrospective Cohort Study

AML - 898

Effect of Nonselective ί-Blocker Use on Postallogeneic Stem Cell Transplant Outcomes in Patients with Myeloid Neoplasms: A Trinetx-Based Retrospective Cohort Study

Madhu Bhargavi Chandra

Poster Presenter: Madhu Bhargavi Chandra

$Thumbnail for Early Real-World Outcomes of Revumenib Versus Venetoclax-Based Salvage Therapy in Relapsed or Refractory Acute Leukemia$

AML - 911

Early Real-World Outcomes of Revumenib Versus Venetoclax-Based Salvage Therapy in Relapsed or Refractory Acute Leukemia

Vishw Patel

Poster Presenter: Vishw Patel

Thumbnail for Clonal Hematopoiesis of Indeterminate Potential Mutations in Neuroendocrine Tumor Patients: Cluster Analysis and Application of Risk Scores

AML - 917

Clonal Hematopoiesis of Indeterminate Potential Mutations in Neuroendocrine Tumor Patients: Cluster Analysis and Application of Risk Scores

Harsha Pattnaik

Poster Presenter: Harsha Pattnaik

AML - 920

Beyond ELN Risk: Clinical Severity and Infections Determine Early Mortality in AML in Peru

Cesar Copaja-Corzo

Poster Presenter: Cesar Copaja-Corzo

$Thumbnail for Venetoclax-Based Salvage Therapy as a Bridge to Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory AML: A Systematic Review and Meta-Analysis$

AML - 923

Venetoclax-Based Salvage Therapy as a Bridge to Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory AML: A Systematic Review and Meta-Analysis

Bhaswanth Bollu

Poster Presenter: Bhaswanth Bollu